Table 2 (abstract A4). See text for description
From: Abstracts of the ICARE 2023 77th SIAARTI National Congress
Observed adverse events | IN | EV | P-value |
|---|---|---|---|
Bradycardia | 0 | 1 | 0.9 |
Desaturation | 0 | 0 | 1 |
Apnea | 0 | 0 | 1 |
Nausea | 0 | 0 | 1 |
Vomit | 0 | 0 | 1 |
Nasal irritation | 0 | 0 | 1 |
From: Abstracts of the ICARE 2023 77th SIAARTI National Congress
Observed adverse events | IN | EV | P-value |
|---|---|---|---|
Bradycardia | 0 | 1 | 0.9 |
Desaturation | 0 | 0 | 1 |
Apnea | 0 | 0 | 1 |
Nausea | 0 | 0 | 1 |
Vomit | 0 | 0 | 1 |
Nasal irritation | 0 | 0 | 1 |